Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Bruzzi

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
Contemporary Clinical Trials Communications|December 25, 2019
NEONOD 2: Rationale and design of a multicenter non-inferiority trial to assess the effect of axillary surgery omission on the outcome of breast cancer patients presenting only micrometastasis in the sentinel lymph node after neoadjuvant chemotherapyCorrado Tinterri, Giuseppe Canavese, Paolo Bruzzi, et al.
Breast (Edinburgh, Scotland)|July 14, 2016
SINODAR ONE, an ongoing randomized clinical trial to assess the role of axillary surgery in breast cancer patients with one or two macrometastatic sentinel nodesCorrado Tinterri, Giuseppe Canavese, Paolo Bruzzi, et al.
Obesity Surgery|January 20, 2017
Prediction of Diabetes Remission at Long Term Following Biliopancreatic DiversionNicola Scopinaro, Gian Franco Adami, Paolo Bruzzi, et al.
Neurology|February 13, 2002
MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patientsMaria Pia Sormani, Paolo Bruzzi, Giancarlo Comi, et al.
Cancer|September 9, 2005
Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studiesAlessandra Gennari, PierFranco Conte, Riccardo Rosso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Raising the bar for antineoplastic agents: how to choose threshold values for superiority trials in advanced solid tumorsAlberto F Sobrero, Alessandro Pastorino, Daniel J Sargent, et al.
Journal of Surgical Oncology|March 30, 2016
Peripherally inserted central catheters (PICCs) in cancer patients under chemotherapy: A prospective study on the incidence of complications and overall failuresSergio Bertoglio, Beatrice Faccini, Luca Lalli, et al.
Plos One|May 22, 2018
Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control studySofia Pavanello, Liliana Varesco, Viviana Gismondi, et al.
Frontiers in Pediatrics|July 5, 2023
The management of achondroplasia in Italy: results from a Delphi panel based on real-world experienceMohamad Maghnie, Paolo Bruzzi, Giorgio Casilli, et al.
Journal of the American College of Cardiology|April 6, 2005
The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptomsCamillo Autore, Paola Bernabò, Caterina Stella Barillà, et al.
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Contemporary Clinical Trials Communications|December 25, 2019
NEONOD 2: Rationale and design of a multicenter non-inferiority trial to assess the effect of axillary surgery omission on the outcome of breast cancer patients presenting only micrometastasis in the sentinel lymph node after neoadjuvant chemotherapyCorrado Tinterri, Giuseppe Canavese, Paolo Bruzzi, et al.
Breast (Edinburgh, Scotland)|July 14, 2016
SINODAR ONE, an ongoing randomized clinical trial to assess the role of axillary surgery in breast cancer patients with one or two macrometastatic sentinel nodesCorrado Tinterri, Giuseppe Canavese, Paolo Bruzzi, et al.
Obesity Surgery|January 20, 2017
Prediction of Diabetes Remission at Long Term Following Biliopancreatic DiversionNicola Scopinaro, Gian Franco Adami, Paolo Bruzzi, et al.
Neurology|February 13, 2002
MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patientsMaria Pia Sormani, Paolo Bruzzi, Giancarlo Comi, et al.
Cancer|September 9, 2005
Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studiesAlessandra Gennari, PierFranco Conte, Riccardo Rosso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Raising the bar for antineoplastic agents: how to choose threshold values for superiority trials in advanced solid tumorsAlberto F Sobrero, Alessandro Pastorino, Daniel J Sargent, et al.
Journal of Surgical Oncology|March 30, 2016
Peripherally inserted central catheters (PICCs) in cancer patients under chemotherapy: A prospective study on the incidence of complications and overall failuresSergio Bertoglio, Beatrice Faccini, Luca Lalli, et al.
Plos One|May 22, 2018
Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control studySofia Pavanello, Liliana Varesco, Viviana Gismondi, et al.
Frontiers in Pediatrics|July 5, 2023
The management of achondroplasia in Italy: results from a Delphi panel based on real-world experienceMohamad Maghnie, Paolo Bruzzi, Giorgio Casilli, et al.
Journal of the American College of Cardiology|April 6, 2005
The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptomsCamillo Autore, Paola Bernabò, Caterina Stella Barillà, et al.
Pageof 16